GNH USA

Europe — EMA

Nimvastid (Rivastigmine)

GNH USA supplies Nimvastid (Rivastigmine), a cholinesterase inhibitor for mild to moderate Alzheimer’s disease and Parkinson’s disease dementia.

Rivastigmine

Request sourcing

1
Pack/s

What is Rivastigmine?

Rivastigmine, the active ingredient in Nimvastid, is a cholinesterase inhibitor presented as an oral formulation for oral use. It is indicated for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease dementia in adults.

GNH USA supplies Nimvastid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring EU‑standard quality for export.

What is Rivastigmine used for?

Nimvastid (rivastigmine) is employed in the management of cognitive decline associated with cholinergic deficiency in dementia disorders.

Mild to moderate Alzheimer’s disease: improves cognition and daily functioning Parkinson’s disease dementia: enhances cognitive performance and behavioral symptoms Alzheimer’s disease‑related dementia: helps maintain activities of daily living

What are the side effects of Rivastigmine?

Rivastigmine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Loss of appetite - Weight loss - Dizziness

Serious or Rare Side Effects: - Severe bradycardia or heart block - Gastrointestinal bleeding or ulceration - Elevated liver enzymes - Allergic reactions such as rash or angioedema - Seizures (rare)

What precautions apply to Rivastigmine?

When prescribing Nimvastid, clinicians should consider the following precautions: - Renal impairment: monitor renal function and adjust therapy as needed - Hepatic impairment: use with caution and observe liver enzymes - Cardiac conduction disorders: assess heart rate and ECG regularly - History of peptic ulcer disease: evaluate risk of gastrointestinal complications - Store at ambient temperature: keep in the original container, protect from moisture and light

What does Rivastigmine interact with?

Rivastigmine can interact with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Anticholinergic agents: may diminish therapeutic benefit - Beta‑blockers: can exacerbate bradycardia - Concurrent cholinesterase inhibitors: risk of additive toxicity

Moderate Interactions (Monitor Closely): - NSAIDs: increase risk of gastrointestinal bleeding - Warfarin: may enhance anticoagulant effect - CYP2D6 inhibitors: may raise rivastigmine plasma concentrations

Frequently asked questions

What is Nimvastid used for?+
Nimvastid contains rivastigmine and is prescribed for the symptomatic treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease dementia. It helps improve cognition, memory, and daily functioning by enhancing cholinergic activity in the brain.
How does rivastigmine work?+
Rivastigmine reversibly inhibits acetylcholinesterase and butyrylcholinesterase, enzymes that break down acetylcholine. By slowing this breakdown, the drug raises acetylcholine levels at neuronal synapses, supporting the cholinergic pathways that are deficient in Alzheimer’s and Parkinson’s disease dementia.
What is the usual dose of Nimvastid?+
The exact dose of Nimvastid is determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dose titration typically starts low and is increased gradually, but the specific regimen should follow the prescriber’s instructions.
Is Nimvastid safe in pregnancy or breastfeeding?+
Safety data for rivastigmine during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and breastfeeding decisions should be made in consultation with a healthcare professional.
How do I order Nimvastid from GNH USA?+
To order Nimvastid, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Nimvastid compare with other cholinesterase inhibitors?+
Nimvastid (rivastigmine) differs from other cholinesterase inhibitors such as donepezil and galantamine by inhibiting both acetylcholinesterase and butyrylcholinesterase, which may offer broader cholinergic enhancement. Its oral formulation is convenient, but side‑effect profiles and dosing schedules vary, so clinicians choose the agent that best matches the patient’s clinical needs.
How should Nimvastid be stored?+
Nimvastid should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.
How is Nimvastid administered?+
Nimvastid is taken orally, usually with food or a meal to reduce gastrointestinal discomfort. The tablets should be swallowed whole with water and not chewed or crushed unless a specific formulation (e.g., oral solution) is prescribed.
What are the most serious risks to watch for while using Nimvastid?+
Serious risks include severe bradycardia or heart block, gastrointestinal bleeding or ulceration, significant liver enzyme elevations, and rare allergic reactions such as rash or angioedema. Patients should be monitored for these events, and any concerning symptoms should prompt immediate medical evaluation.
Who should not use Nimvastid?+
Nimvastid is contraindicated in patients with known hypersensitivity to rivastigmine or any excipients, those with severe cardiac conduction disorders (e.g., sick‑sinus syndrome without a pacemaker), and individuals with active peptic ulcer disease or gastrointestinal bleeding. Caution is also advised for patients with severe renal or hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Rivastigmine
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products

Exelon 4.6 mg/24h

Exelon 4.6 mg/24h

Rivastigmine · 4.6 mg/24h

Exelon
PATCH, EXTENDED RELEASE
Novartis Pharmaceuticals Corporation
USA
Exelon 9.5 mg/24h

Exelon 9.5 mg/24h

Rivastigmine · 9.5 mg/24h

Exelon
PATCH, EXTENDED RELEASE
Novartis Pharmaceuticals Corporation
USA
Exelon 13.3 mg/24h

Exelon 13.3 mg/24h

Rivastigmine · 13.3 mg/24h

Exelon
PATCH, EXTENDED RELEASE
Novartis Pharmaceuticals Corporation
USA
Rivastigmine 4.6 mg/24h

Rivastigmine 4.6 mg/24h

Rivastigmine · 4.6 mg/24h

Rivastigmine
PATCH
Mylan Pharmaceuticals Inc.
USA